Trials / Unknown
UnknownNCT05933317
A Long-term Follow-up Study of Pulmonary Function Changes Using Phase-resolved Functional Lung MRI in Patients With COVID-19
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Beijing Chao Yang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
So far, the number of COVID-19 infections worldwide has exceeded 700 million. Long-term damage to the lungs is a major sequela of COVID infection. Pulmonary function testing is an important means for the evaluation of lung damage. MRI examinations with free breathing and no contrast agent can prevent patients from suffering from ionizing radiation damage caused by multiple CT examinations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Functional lung MRI | Functional lung MRI |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
- First posted
- 2023-07-06
- Last updated
- 2023-07-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05933317. Inclusion in this directory is not an endorsement.